Antibody neutralization of retargeted measles viruses.

Antibody neutralization of retargeted measles viruses.
复制标题

DOI:
10.1016/j.virol.2014.01.027
复制
发表时间:
2014-04
期刊:
影响因子:
3.7
通讯作者:
Russell, Stephen J.
Russell, Stephen J.
中科院分区:
医学3区
文献类型:
--
作者:
Lech, Patrycja J.;Pappoe, Roland;Nakamura, Takafumi;Russell, Stephen J.

文献摘要

参考文献

被引文献

相似文献

Please try later.
The measles virus (MV) vaccine lineage is a promising oncolytic but prior exposure to the measles vaccine or wild-type MV strains limits treatment utility due to the presence of anti-measles antibodies. MV entry can be redirected by displaying a polypeptide ligand on the Hemagglutinin (H) C-terminus. We hypothesized that retargeted MV would escape neutralization by monoclonal antibodies (mAbs) recognizing the H receptor-binding surface and be less susceptible to neutralization by human antisera. Using chimeric H proteins, with and without mutations that ablate MV receptor binding, we show that retargeted MVs escape mAbs that target the H receptor-binding surface by virtue of mutations that ablate infection via SLAM and CD46. However, C-terminally displayed domains do not mediate virus entry in the presence of human antibodies that bind to the underlying H domain. In conclusion, utility of retargeted oncolytic measles viruses does not extend to evasion of human serum neutralization.
DOI: 10.1038/nsmb.1969
发表时间: 2011-02-01
影响因子: 16.8
作者:
Hashiguchi, Takao;Ose, Toyoyuki;Yanagi, Yusuke
通讯作者: Yanagi, Yusuke
DOI: 10.1128/jvi.73.11.9568-9575.1999
发表时间: 1999-11-01
影响因子: 5.4
作者:
Duprex, WP;McQuaid, S;Rima, BK
通讯作者: Rima, BK
DOI: 10.1158/1078-0432.ccr-05-1803
发表时间: 2006-03-15
影响因子: 11.5
作者:
Hasegawa, K;Pham, L;Peng, KW
通讯作者: Peng, KW
DOI: 10.1089/10430340050015437
发表时间: 2000-04-10
期刊: HUMAN GENE THERAPY
影响因子: 4.2
作者:
Fielding, AK;Chapel-Fernandes, S;Russell, SJ
通讯作者: Russell, SJ
麻疹病毒血凝素:对细胞进入的结构见解和麻疹疫苗。
DOI: 10.3389/fmicb.2011.00247
发表时间: 2011
影响因子: 5.2
作者:
Hashiguchi T;Maenaka K;Yanagi Y
通讯作者: Yanagi Y